Developmental Exposure to Organophosphate Flame Retardants Elicits Overt Toxicity and Alters Behavior in Early Life Stage Zebrafish (Danio rerio)

por Dishaw, Laura V., Hunter, Deborah L., Padnos, Beth, Padilla, Stephanie, Stapleton, Heather M.
Publicado en Toxicol Sci (2014)

Acute and developmental behavioral effects of flame retardants and related chemicals in zebrafish

por Jarema, Kimberly A., Hunter, Deborah L., Shaffer, Rachel M., Behl, Mamta, Padilla, Stephanie
Publicado en Neurotoxicol Teratol (2015)

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

por Weisberg, Stuart P., Hunter, Deborah, Huber, Reid, Lemieux, Jacob, Slaymaker, Sarah, Vaddi, Kris, Charo, Israel, Leibel, Rudolph L., Ferrante, Anthony W.
Publicado 2006

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

por Weisberg, Stuart P., Hunter, Deborah, Huber, Reid, Lemieux, Jacob, Slaymaker, Sarah, Vaddi, Kris, Charo, Israel, Leibel, Rudolph L., Ferrante, Anthony W.
Publicado 2006

Zebrafish Locomotor Responses Reveal Irritant Effects of Fine Particulate Matter Extracts and a Role for TRPA1

por Stevens, Joey S, Padilla, Stephanie, DeMarini, David M, Hunter, Deborah L, Martin, W Kyle, Thompson, Leslie C, Gilmour, M Ian, Hazari, Mehdi S, Farraj, Aimen K
Publicado en Toxicol Sci (2018)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom...

por Mesa, Ruben, Vannucchi, Alessandro M., Yacoub, Abdulraheem, Zachee, Pierre, Garg, Mamta, Lyons, Roger, Koschmieder, Steffen, Rinaldi, Ciro, Byrne, Jennifer, Hasan, Yasmin, Passamonti, Francesco, Verstovsek, Srdan, Hunter, Deborah, Jones, Mark M., Zhen, Huiling, Habr, Dany, Martino, Bruno
Publicado en Br J Haematol (2016)

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis

por Mascarenhas, John O., Talpaz, Moshe, Gupta, Vikas, Foltz, Lynda M., Savona, Michael R., Paquette, Ronald, Turner, A. Robert, Coughlin, Paul, Winton, Elliott, Burn, Timothy C., O’Neill, Peter, Clark, Jason, Hunter, Deborah, Assad, Albert, Hoffman, Ronald, Verstovsek, Srdan
Publicado en Haematologica (2017)

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine...

por Hurwitz, Herbert I., Uppal, Nikhil, Wagner, Stephanie A., Bendell, Johanna C., Beck, J. Thaddeus, Wade, Seaborn M., Nemunaitis, John J., Stella, Philip J., Pipas, J. Marc, Wainberg, Zev A., Manges, Robert, Garrett, William M., Hunter, Deborah S., Clark, Jason, Leopold, Lance, Sandor, Victor, Levy, Richard S.
Publicado en J Clin Oncol (2015)

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

por Mesa, Ruben A., Kiladjian, Jean-Jacques, Verstovsek, Srdan, Al-Ali, Haifa Kathrin, Gotlib, Jason, Gisslinger, Heinz, Levy, Richard, Siulnik, Andres, Gupta, Vikas, Khan, Mahmudul, DiPersio, John F., McQuitty, Mari, Catalano, John V., Hunter, Deborah S., Knoops, Laurent, Deininger, Michael, Cervantes, Francisco, Miller, Carole, Vannucchi, Alessandro M., Silver, Richard T., Barbui, Tiziano, Talpaz, Moshe, Barosi, Giovanni, Winton, Elliott F., Mendeson, Estella, Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Sun, William, Sandor, Victor, Kantarjian, Hagop M., Harrison, Claire
Publicado 2014